DVAX Related Analyst Ratings
-
Jefferies Says Dynavax (DVAX) Should Be Bought on Weakness
-
Jefferies Would Still Buy Dynavax Technologies (DVAX) if CRL Issued Friday
-
JPMorgan Starts Dynavax Technologies (DVAX) at Neutral
-
At ~$2/Sh Jefferies Sees a Compelling Entry Point in Dynavax (DVAX)
-
Jefferies Says Dynavax (DVAX) Briefing Documents Bode Well For Panel
-
JMP Securities Starts Dynavax Technologies (DVAX) at Market Outperform
-
FDA Approval of Dynavax's (DVAX) Groundbreaking Hep-B Vacccine Could Double Its Value - Cramer
-
William Blair Reiterates an 'Outperform' on Dynavax (DVAX); Heplisav VRBPAC Panel Set - What to Watch For
-
Jefferies Maintains a 'Buy' on Dynavax Technologies (DVAX); Next Catalyst For Heplisav
-
Jefferies Maintains Bullish Stance on Dynavax (DVAX) On Heplisav CKD Data Update
-
Jefferies Lowers Numbers on Dynavax (DVOX), Keeps "Buy" Rating
-
Jefferies Maintains a 'Buy' on Dynavax Technologies (DVAX); Broad Adult Label Should Be A Positive For Heplisav and Diabetes Opportunity
-
McNicoll Lewis & Vlak Starts Dynavax Technologies (DVAX) at Buy
-
Jefferies Encourages Investors to Buy Shares of Dynavax Technologies (DVAX) on Weakness
-
Jefferies Positive On Dynavax (DVAX) and Heplisav
-
William Blair Starts Dynavax Technologies (DVAX) at Outperform
-
Wedbush Assumes Coverage on Dynavax Technologies (DVAX) at Outperform; Optimistic on HEPLISAV
-
Cowen Starts Dynavax Technologies (DVAX) at Outperform
-
Jefferies Starts Dynavax Technologies (DVAX) at Buy
-
Dynavax (DVAX) Shares Jump as Wedbush Issues After-Hours Upgrade
-
Credit Suisse Downgrades Dynavax (DVAX) to Neutral
-
Oppenheimer Initiates Coverage on Dynavax (DVAX) with a Perform
-
Merriman Curhan Downgrades Dynavax (DVAX) to Neutral
-
Oppenheimer upgrades Dynavax Technologies (DVAX) to Outperform
-
IDP, ANDS, DVAX Could See Action Related to Pfizer's Deal to Acquire Coley
-
Bear Stearns upgrades Dynavax (DVAX) to Outperform
-
JMP Securities downgrades DVAX to Market Perform
-
CIBC Initiates DVAX
-
Pfizer's Recent Deal w/Coley Could Benefit HBY - analyst
-
Bear Stearns Downgrades DVAX
-
DVAX started at Market Perform at JMP Securities; $11 price tgt
Back to DVAX Stock Lookup
